BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27775083)

  • 1. Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.
    Céspedes MV; Fernández Y; Unzueta U; Mendoza R; Seras-Franzoso J; Sánchez-Chardi A; Álamo P; Toledo-Rubio V; Ferrer-Miralles N; Vázquez E; Schwartz S; Abasolo I; Corchero JL; Mangues R; Villaverde A
    Sci Rep; 2016 Oct; 6():35765. PubMed ID: 27775083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci.
    Céspedes MV; Cano-Garrido O; Álamo P; Sala R; Gallardo A; Serna N; Falgàs A; Voltà-Durán E; Casanova I; Sánchez-Chardi A; López-Laguna H; Sánchez-García L; Sánchez JM; Unzueta U; Vázquez E; Mangues R; Villaverde A
    Adv Mater; 2020 Feb; 32(7):e1907348. PubMed ID: 31879981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.
    Cano-Garrido O; Rodríguez-Carmona E; Díez-Gil C; Vázquez E; Elizondo E; Cubarsi R; Seras-Franzoso J; Corchero JL; Rinas U; Ratera I; Ventosa N; Veciana J; Villaverde A; García-Fruitós E
    Acta Biomater; 2013 Apr; 9(4):6134-42. PubMed ID: 23220450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Inclusion Bodies: Discovering Their Better Half.
    Rinas U; Garcia-Fruitós E; Corchero JL; Vázquez E; Seras-Franzoso J; Villaverde A
    Trends Biochem Sci; 2017 Sep; 42(9):726-737. PubMed ID: 28254353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs.
    Seras-Franzoso J; Peebo K; Luis Corchero J; Tsimbouri PM; Unzueta U; Rinas U; Dalby MJ; Vazquez E; García-Fruitós E; Villaverde A
    Nanomedicine (Lond); 2013 Oct; 8(10):1587-99. PubMed ID: 23394133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial inclusion bodies are industrially exploitable amyloids.
    de Marco A; Ferrer-Miralles N; Garcia-Fruitós E; Mitraki A; Peternel S; Rinas U; Trujillo-Roldán MA; Valdez-Cruz NA; Vázquez E; Villaverde A
    FEMS Microbiol Rev; 2019 Jan; 43(1):53-72. PubMed ID: 30357330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering tumor cell targeting in nanoscale amyloidal materials.
    Unzueta U; Seras-Franzoso J; Céspedes MV; Saccardo P; Cortés F; Rueda F; Garcia-Fruitós E; Ferrer-Miralles N; Mangues R; Vázquez E; Villaverde A
    Nanotechnology; 2017 Jan; 28(1):015102. PubMed ID: 27893441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells.
    Seras-Franzoso J; Sánchez-Chardi A; Garcia-Fruitós E; Vázquez E; Villaverde A
    Soft Matter; 2016 Apr; 12(14):3451-60. PubMed ID: 26956912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Stabilization of Clinically Oriented Oligomeric Proteins During their Transit through Synthetic Secretory Amyloids.
    Sánchez JM; López-Laguna H; Parladé E; Somma AD; Livieri AL; Álamo P; Mangues R; Unzueta U; Villaverde A; Vázquez E
    Adv Sci (Weinh); 2024 Jun; 11(21):e2309427. PubMed ID: 38501900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional amyloids signal their arrival.
    Badtke MP; Hammer ND; Chapman MR
    Sci Signal; 2009 Jul; 2(80):pe43. PubMed ID: 19622831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Intracellular Amyloid Formation in Fixed and Live Bacteria Using Fluorescence Microscopy.
    Marín J; Aguilera P; Lagos R; Marcoleta A
    Methods Mol Biol; 2022; 2538():261-273. PubMed ID: 35951305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Nanofibrils as Storage Forms of Peptide Drugs and Hormones.
    Jacob RS; Anoop A; Maji SK
    Adv Exp Med Biol; 2019; 1174():265-290. PubMed ID: 31713202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin B (secretogranin I), a neuroendocrine-regulated secretory protein, is sorted to exocrine secretory granules in transgenic mice.
    Natori S; King A; Hellwig A; Weiss U; Iguchi H; Tsuchiya B; Kameya T; Takayanagi R; Nawata H; Huttner WB
    EMBO J; 1998 Jun; 17(12):3277-89. PubMed ID: 9628865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Paradigms for Synthetic Design of Functional Amyloids.
    Wang Y; Pu J; An B; Lu TK; Zhong C
    J Mol Biol; 2018 Oct; 430(20):3720-3734. PubMed ID: 29702108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins associated with immunopurified granules from a model pancreatic islet beta-cell system: proteomic snapshot of an endocrine secretory granule.
    Hickey AJ; Bradley JW; Skea GL; Middleditch MJ; Buchanan CM; Phillips AR; Cooper GJ
    J Proteome Res; 2009 Jan; 8(1):178-86. PubMed ID: 19055480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach.
    Unzueta U; Cespedes MV; Sala R; Alamo P; Sánchez-Chardi A; Pesarrodona M; Sánchez-García L; Cano-Garrido O; Villaverde A; Vázquez E; Mangues R; Seras-Franzoso J
    J Control Release; 2018 Jun; 279():29-39. PubMed ID: 29641987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Inclusion Bodies for Clinical Development.
    Sánchez JM; López-Laguna H; Álamo P; Serna N; Sánchez-Chardi A; Nolan V; Cano-Garrido O; Casanova I; Unzueta U; Vazquez E; Mangues R; Villaverde A
    Adv Sci (Weinh); 2020 Feb; 7(3):1902420. PubMed ID: 32042562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial inclusion bodies: making gold from waste.
    García-Fruitós E; Vázquez E; Díez-Gil C; Corchero JL; Seras-Franzoso J; Ratera I; Veciana J; Villaverde A
    Trends Biotechnol; 2012 Feb; 30(2):65-70. PubMed ID: 22037492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies.
    Sánchez JM; Carratalá JV; Serna N; Unzueta U; Nolan V; Sánchez-Chardi A; Voltà-Durán E; López-Laguna H; Ferrer-Miralles N; Villaverde A; Vazquez E
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35335976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of human neutrophils with sera containing HLA Class I alloantibody causes preferential degranulation of azurophilic granules and secretory vesicles.
    Takahashi D; Fujihara M; Azuma H; Miyazaki T; Uchimura D; Wakamoto S; Sato S; Kato T; Ikeda H
    Vox Sang; 2010 May; 98(4):560-6. PubMed ID: 20158696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.